Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-03

FDA Approved: EZETIMIBE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for ezetimibe from Aurobindo Pharma Limited, confirming regulatory approval of this generic ezetimibe product under its …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)

Snippet

SUPPL AP for EZETIMIBE (EZETIMIBE)